Form N-CSRS - Certified Shareholder Report, Semi-Annual:
SEC Accession No. 0001104659-25-057746
Filing Date
2025-06-09
Accepted
2025-06-09 14:15:52
Documents
11
Period of Report
2025-03-31
Effectiveness Date
2025-06-09

Document Format Files

Seq Description Document Type Size
1 N-CSRS tm2516624d12_ncsrs.htm N-CSRS 905862
2 EXHIBIT 99.CERT tm2516624d12_ex99-cert.htm EX-99.CERT 19576
3 EXHIBIT 99.906CERT tm2516624d12_ex99-906cert.htm EX-99.906CERT 6161
4 EXHIBIT 99.(C)(1) tm2516624d12_ex99-xcx1.htm EX-99.(C)(1) 95265
5 EXHIBIT 99.(C)(2) tm2516624d12_ex99-xcx2.htm EX-99.(C)(2) 91010
6 GRAPHIC tm2516624d12_ex99-xcx1img001.jpg GRAPHIC 11083
7 GRAPHIC tm2516624d12_ex99-xcx2img001.jpg GRAPHIC 4625
8 GRAPHIC tm2516624d12hqlreporti001.gif GRAPHIC 299495
9 GRAPHIC tm2516624d12hqlreporti002.gif GRAPHIC 1018
10 GRAPHIC tm2516624d12hqlreporti003.jpg GRAPHIC 17872
11 GRAPHIC tm2516624d12hqlreporti004.jpg GRAPHIC 7726
  Complete submission text file 0001104659-25-057746.txt   1590619
Mailing Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103
Business Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103 6177728515
abrdn Life Sciences Investors (Filer) CIK: 0000884121 (see all company filings)

EIN.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
Type: N-CSRS | Act: 40 | File No.: 811-06565 | Film No.: 251033574